What if aging research has been studying the wrong sex?

Longevity.Technology is growing fast; we are open to conversations with prospective partners and investors who share our vision.

Please get in touch if you are interested:

A new evolutionary framework suggests research into female biology could reveal overlooked clues to healthier aging.

For decades, geroscience has searched for the molecular machinery that drives aging – identifying pathways, perturbing genes and cataloguing the cellular hallmarks that gradually erode health. A new Perspective published in Cell suggests the field may also have been overlooking something rather more fundamental: where it has been looking in the first place. Rather than treating female biology primarily as a source of experimental variability, the authors argue it may represent one of evolution’s richest repositories of resilience mechanisms [1].

The Reproductive Resilience Hypothesis (RRH), developed by researchers at the Buck Institute for Research on Aging, makes a fairly bold proposal: that reproduction and longevity need not be natural enemies. In species where an offspring’s survival – or a colony’s – depends on the mother sticking around, natural selection may have quietly favoured physiology that keeps her going rather than using her up. Queen bees manage this trick rather spectacularly, living years while their workers manage weeks; the authors suspect humans may be doing a subtler version of the same thing [1].

None of this is proven, exactly – it is an evolutionary hypothesis, not a discovered mechanism. But a good hypothesis has a way of quietly rearranging what a field thinks is worth measuring, and this one arrives with its sleeves already rolled up.

Longevity.Technology: Underrepresentation is the usual complaint about women in biomedical research, and it is a fair one; trial cohorts, model organisms and reference ranges have skewed male for decades. The Reproductive Resilience Hypothesis is making a different, rather more interesting claim. Not that women have been left out of the aging conversation, but that female biology may be where the actual answers were sitting all along – shaped, the theory goes, by evolutionary pressure to survive long enough to reproduce repeatedly, raise young and hold up under exactly the kind of physiological demand that tends to break things. That does not make this paper a rewrite of evolutionary theory – nor, importantly, does it demonstrate that ovarian aging is the master switch for systemic aging. It is, after all, a hypothesis. Yet good hypotheses have a habit of changing where scientists look. If reproductive history, menopause and ovarian signaling become variables to interrogate rather than sources of experimental ‘noise’, they could reshape everything from animal models and biomarker development to clinical trial design. Geroscience has spent decades searching for the molecular levers that slow aging; wouldn’t it be ironic if one of the next advances came not from discovering an entirely new pathway, but from paying closer attention to biology that has been there all along?

Beyond the disposable soma

Classical evolutionary theories, including the disposable soma hypothesis, have long described reproduction as an energetic trade-off; resources invested in producing offspring are resources unavailable for maintaining the body. The authors do not reject those theories. Rather, they suggest they may be incomplete. RRH proposes that where future reproductive success depends on continued survival – whether through repeated pregnancies, parental care or support of kin – evolution may instead favor mechanisms that strengthen an organism’s ability to withstand physiological stress [1].

The pattern shows up again and again once you start looking for it. Female mammals routinely outlive males despite the metabolic bill that pregnancy and lactation leave behind; the honeybee’s colony-mates follow the same logic; and in species where fathers actually pull their weight in childcare, the longevity gap between the sexes narrows, sometimes to nothing, sometimes in reverse. Biologists have generally filed these under “exceptions.” The authors’ suspicion is that they are not exceptions at all – they are the rule, and everything else is the anomaly.

“If we wish to understand why organisms age, nature points us toward studying women, the sex in which reproduction most profoundly shapes the course of aging,” says senior author Professor Pankaj Kapahi.

Lead author Dr Parminder Singh adds: “The Reproductive Resilience Hypothesis is a new evolutionary framework for understanding why reproduction accelerates aging in some biological settings but is associated with exceptional longevity in others. The central question is not simply how much an organism reproduces. It is whether continued survival remains important for future reproductive success, offspring survival, caregiving, or inclusive fitness.”

Dr Parminder Singh is lead author on the new Perspective

More than hormones

The framework also has something to say about menopause – and it is not simply “the end of fertility” or “declining estrogen,” which is how the condition is usually filed. For the authors, it is something closer to a switchboard going quiet: throughout reproductive life, the ovaries are in constant conversation with metabolism, immunity, bone, tissue repair and the brain, and menopause is what happens when that conversation starts dropping calls [1]. Vulnerabilities that were once quietly managed in the background start to surface, not because any single organ failed, but because nobody was coordinating them anymore.

None of which means the ovaries are secretly running the whole show. The paper is careful on this point: reproductive decline is one voice in a much noisier room that also includes genomic instability, mitochondrial fatigue, exhausted stem cells, tissue-specific degeneration and a general drift toward chronic inflammation [1]. These processes were always going to happen. What RRH adds is a claim about pacing – that losing reproductive resilience may not cause the noise, but it does seem to change the tempo.

“The ovary should not be viewed only as an organ that produces eggs and sex hormones,” says Singh. “It may also function as a communication hub whose endocrine, metabolic, immune, and paracrine signals help coordinate the physiological state of distant organs. When this communication declines, the consequences may extend far beyond fertility.”

Kapahi is similarly cautious.

“We are not proposing that ovarian aging is the sole cause of systemic aging,” he says. “Rather, ovarian decline may remove an important layer of physiological coordination. That loss can interact with chronological aging, genetics, inflammation, metabolism, environmental exposures, and tissue-specific damage.”

Changing the questions

Perhaps the paper’s most practical contribution lies in its implications for future research. The authors outline eleven areas in which RRH could influence experimental design, arguing that reproductive history should become a routine variable in human aging studies and that animal models should extend beyond the long-standing comparison between males and young, nulliparous females. Pregnancy, lactation, menopause, hormone therapy and ovarian surgery, they suggest, may each provide valuable insight into resilience, disease susceptibility and therapeutic response [1].

The paper’s wish list for future research is fairly specific. Biomarkers ought to be built around reproductive state rather than chronological age alone. The ovary’s chemical vocabulary needs a proper hearing – there is more coming out of it than the usual sex hormones, and nobody has really been listening. And the naked mole-rat, along with its eusocial cousins in the insect world, deserves rather more attention than it currently gets, given that it seems to have solved the fertility-versus-longevity problem that everyone else is still grappling with [1].

None of this, the authors are careful to note, promises longer fertility. The promise, if there is one, is a longer run of ordinary good health – which may turn out to be the more useful gift [1].

“Studying females is not a specialized branch of aging research,” says Kapahi. “It is an opportunity to discover biological mechanisms that evolution has already developed to preserve survival under the demanding conditions of reproduction and caregiving.”

Pankaj Kapahi Buck Institute researches aging
Professor Pankaj Kapahi (L) is a senior author on the new paper

Singh agrees.

“Female biology should be prioritized not only to correct a longstanding gap in biomedical research, but because it may reveal resilience mechanisms that help us understand how to extend healthspan in both women and men.”

Following evolution’s clues

The Reproductive Resilience Hypothesis will now stand or fall on the evidence that follows it. Yet whether every prediction proves correct may not be the most enduring consequence of the paper. Occasionally, progress begins not with a new technology or therapeutic, but with a different question altogether – and those are often the questions that can redirect an entire field.

Photographs/images courtesy of The Buck Institute for Research on Aging

[1] 10.1016/j.cell.2026.07.013

Eleanor Garth

Editor

Now a science and medicine journalist, Eleanor worked as a consultant for university spin-out companies and provided research support at Imperial College London and various London hospitals in a former life.

With a keen interest in all things geroscience, Eleanor covers the biological mechanisms of aging, highlighting how interventions – from nutritional strategies to advanced therapeutics – can influence the aging process at a cellular level. She also investigates the broader implications of aging research, including the integration of longevity science into healthcare strategy and the expanding wellness economy. Her work (hopefully) provides insights into how these developments are shaping the emerging landscape of healthspan optimization and age-related innovation.

Sign up for our daily newsletter to get our biggest longevity stories, handpicked for you each day.

The latest longevity science, investment, innovation and insight, delivered every morning.

Unlock Longevity Biotech Report for FREE